Galapagos NV
GLPG
#4557
Rank
ยฃ1.67 B
Marketcap
ยฃ25.09
Share price
-1.20%
Change (1 day)
18.68%
Change (1 year)

Earnings for Galapagos NV (GLPG)

Earnings in 2025 (TTM): -ยฃ0.4 Billion

According to Galapagos NV's latest financial reports the company's current earnings are ยฃ0.32 Billion. In 2024 the company made an earning of -ยฃ4.3 Million, an increase over its 2023 earnings that were of -ยฃ24.92 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Galapagos NV from 2015 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ0.4 Billion9174.86%
2024 -ยฃ4.3 Million-82.77%
2023 -ยฃ24.92 Million-85.59%
2022 -ยฃ0.18 Billion60.71%
2021 -ยฃ0.11 Billion-60.08%
2020 -ยฃ0.27 Billion-331.44%
2019 ยฃ0.11 B-523.76%
2018 -ยฃ27.49 Million-72.34%
2017 -ยฃ99.4 Million-329.59%
2016 ยฃ43.29 M-144.3%
2015 -ยฃ97.72 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
ยฃ24.06 B-6,184.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
ยฃ6.04 B-1,628.56%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
ยฃ1.23 B-411.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ6.76 B-1,809.31%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
ยฃ17.15 B-4,437.01%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ9.72 B-2,558.70%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
ยฃ6.92 B-1,851.12%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-ยฃ39.73 Million-89.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.59 B-504.21%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel